Quick Takeaways
- SUSQUEHANNA SECURITIES, LLC filed SCHEDULE 13G for Nektar Therapeutics Common Stock, $0.0001 par value per share (NKTR).
- Disclosed ownership: 6.3%.
- Date of event: 30 Sep 2025.
SUSQUEHANNA SECURITIES, LLC - 30 Sep 2025 SCHEDULE 13G Report for Nektar Therapeutics Common Stock, $0.0001 par value per share (NKTR)
- Filing Manager
- SUSQUEHANNA SECURITIES, LLC
- Reporting Manager
- Susquehanna Portfolio Strategies, LLC
- Symbol
- NKTR
- Shares outstanding
- 19,616,889 shares
- Disclosed Ownership
- 1,235,864 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Nov 2025, 17:45:11 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"SUSQUEHANNA SECURITIES, LLC disclosed 6.3% ownership in Nektar Therapeutics Common Stock, $0.0001 par value per share (NKTR) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 17:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Susquehanna Portfolio Strategies, LLC | 6.3% | 1,235,864 | 16,057 | 1,235,864 | /s/ Brian Sopinsky | Brian Sopinsky, Assistant Secretary | |
| Susquehanna Securities, LLC | 6.3% | 1,235,864 | 1,219,807 | 1,235,864 | /s/ Brian Sopinsky | Brian Sopinsky, Secretary |